Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(9 sites)
Germany
University Hospital Aachen, Department of General, Visceral and Transplant Surgery, Aachen Charité Universitätsmedizin, Department of Nephrology and Medical Intensive Care, Berlin University Hospital Dresden, Division of Nephrology, Dresden University Medical Center Hamburg-Eppendorf, Internal Medicine III (Nephrology, Rheumatology, Endocrinology), Hamburg Hannover Medical School, Department of General, Visceral and Transplant Surgery, Hanover University Hospital Jena, Internal Medicine III, Nephrology, Jena University Medical Center of the Johannes Gutenberg University Mainz, Medical Clinic I. (Nephrology), Mainz University Hospital Münster, Medical Clinic D, Münster University Hospital Regensburg, Department of Nephrology, Regensburg